Skip to main content
. Author manuscript; available in PMC: 2022 Jul 2.
Published in final edited form as: Nature. 2022 Apr 20;605(7908):139–145. doi: 10.1038/s41586-022-04632-1

Extended Data Figure 3. Recognition of cancer cell antigens by NK1.1+ αβILTCk-TCRs.

Extended Data Figure 3.

a, A representative flow plot showing the gating strategy used to isolate NK1.1+ αβILTCks and PD-1+ T cells (TCs) from PyMT mice. NK1.1+ αβILTCks are identified as CD45+TCRβ+CD8α+PD-1NK1.1+ whereas PD-1+ TCs are defined as CD45+TCRβ+CD8α+PD-1+NK1.1. b, A histogram showing the distribution of CDR3 lengths of TCRα and TCRβ pairs isolated from αβILTCks and PD-1+ TCs. Data are pooled from two independent experiments. c, Flow cytometric analysis showing the frequency of GFP+ cells among CD8+ and CD8 reporter cell line expressing indicated TCRs 24 hours after co-culturing with primary PyMT cancer cells or splenocytes pulsed with the SIINFEKL peptide (OVA257–264). Data are representative of three independent experiments. d, Frequency of GFP+ cells among CD8 reporter cell line expressing indicated NK1.1+ αβILTCk-derived TCRs 24 hours after co-culturing with primary PyMT cancer cells. n = 3 for each TCR. All statistical data are shown as mean ± S.D (biologically independent mice in a-c and independent samples in d).